681 studies found for:    GLP-1
Show Display Options
Rank Status Study
1 Completed Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans
Condition: Hyperglycemia
Interventions: Drug: GLP-1 control;   Drug: GLP-1 and Exendin(9-39) 300;   Drug: saline control;   Drug: GLP-1 and Exendin(9-39) 600;   Drug: GLP-1 and Exendin(9-39) 900;   Drug: GLP-1 and Exendin(9-39) 1200
2 Unknown  Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery
Condition: CABG
Interventions: Drug: Placebo;   Drug: GLP-1 (7-36) amide
3 Recruiting Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
Conditions: Coronary Artery Disease;   Diabetes Mellitus Type 2
Intervention: Drug: Glucagon-Like-Peptide-1/Regadenoson/Perflutren Lipid Microsphere
4 Recruiting Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
Condition: Post-bariatric Surgery
Interventions: Drug: exendin-(9-39);   Drug: exendin -(9-39)
5 Recruiting GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
Condition: Healthy
Interventions: Other: 1,5 nmol/kg,GLP-1 sc injection;   Other: 1,5 nmol/kg GLP-1 9-36amide, sc injection;   Other: Exendin-4 ;10 ug,sc injection;   Other: saline
6 Completed
Has Results
GLP1R Polymorphisms and Response to GLP1
Condition: Diabetes
Intervention: Drug: GLP-1
7 Not yet recruiting GLP-1 Loading During Elective Percutaneous Coronary Intervention
Conditions: Angina Pectoris;   Myocardial Infarction;   Reperfusion Injury;   Coronary Heart Disease
Intervention: Drug: GLP-1
8 Completed The Effect of GLP-1 on the Inhibition of Glucagon Secretion
Conditions: Type 2 Diabetes;   Type 1 Diabetes
Interventions: Drug: Native human Glucagon-like Peptide-1 ( GLP-1(7-36));   Drug: NaCl
9 Completed Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients
Conditions: Diabetes Mellitus Type 2;   Hyperglycemia
Interventions: Drug: GLP-1;   Drug: Human regular insulin intravenously
10 Recruiting Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes
Conditions: Obesity;   Type 2 Diabetes
Interventions: Drug: Liraglutide treatment 12 weeks;   Drug: insulin glargine treatment;   Drug: GLP-1 receptor antagonist
11 Completed Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
Condition: Healthy
Intervention: Drug: native glp-1 (7-36)
12 Completed Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
Conditions: Type 2 Diabetes Mellitus;   Healthy
Interventions: Drug: GLP-1 Low Dose;   Drug: GLP-1 Mid-Range Dose;   Drug: GLP-1 High Dose;   Drug: Placebo
13 Recruiting Meal Timing on Postprandial Glucose, Insulin and GLP-1 in Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Other: High Calorie Breakfast (BTdiet);   Other: High Caloric Dinner (DTdiet)
14 Active, not recruiting Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects
Condition: Vagotomy, Truncal
Interventions: Drug: GLP-1;   Other: Saline
15 Recruiting The Microvascular Function of GLP-1 and Its Analogues
Conditions: Type 2 Diabetes;   Obesity
Interventions: Drug: GLP-1;   Drug: Placebo
16 Enrolling by invitation The Efficacy of GLP - 1(7-36) Amide for Glycemic Control in Critically Ill Patients
Conditions: Critically Ill;   Hypoglycemia
Interventions: Drug: Glucagon-Like Peptide-1;   Drug: Saline
17 Completed The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
Conditions: Type 2 Diabetes;   Stroke;   Myocardial Infarction
Interventions: Drug: glucagon-like-peptide-1;   Drug: placebo
18 Recruiting GLP-1 and Microvascular Function in Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Liraglutide;   Other: diet;   Drug: Aspirin
19 Recruiting GLP-1 and Hypoglycemia
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Glucagon-Like Peptide- 1 (GLP-1) infusion;   Other: Placebo Comparator: Saline Infusion
20 Recruiting Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1
Condition: Hypoglycaemia
Interventions: Drug: GLP-1;   Drug: Placebo (Saline);   Drug: TNF-alfa;   Other: OGTT;   Other: IVGTT

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years